HGPE: The revenue share of major products in the fields of robot reducers and humanoid robots is 1.76%
I'm LongbridgeAI, I can summarize articles.HGPE announced that the cumulative deviation value of the closing price increase of its stock has exceeded 30% for three consecutive trading days, which constitutes abnormal fluctuations. The company's main product revenue in the fields of robotic reducers and humanoid robots is RMB 17.5223 million, accounting for 1.76% of its main business revenue. There is uncertainty regarding the market space for humanoid robots and the company's future business proportion, reminding investors to pay attention to risks
According to the announcement from HGPE (301261.SZ), the company's stock trading has experienced a cumulative closing price deviation of over 30% during three consecutive trading days (March 10, 2025, March 11, 2025, and March 12, 2025). This situation falls under the category of abnormal stock trading fluctuations as per the relevant regulations of the Shenzhen Stock Exchange.
The company has noted the recent high market interest in humanoid robot concepts. The main products in the field of robot reducers and humanoid robots include RV reducers, harmonic reducer components, connectors for upper and lower limbs, brackets, and other structural components, with related revenue in 2024 amounting to 17.5223 million yuan, accounting for 1.76% of the main business revenue. Currently, there is uncertainty regarding the market space for downstream applications of humanoid robots and the future proportion of the company's related business. Investors are advised to pay attention to investment risks and make cautious decisions